DRAPALIN Pharmaceuticals GmbH, the only Munich-based pharmaceutical company in the field of medical cannabis, is now a LöwenPartner.
DRAPALIN Pharmaceuticals GmbH, the only Munich-based pharmaceutical company in the field of medical cannabis, is now a LöwenPartner.
DRAPALIN’s company founders, Ilya and Ivan Garev, come from Kyiv in Ukraine. “When we came to Germany in 1998, our father explained to us right away that as a Munich resident, you support the Sechzger. As big soccer fans, we have been following the “Löwen” ever since. In our eyes, they stand for loyalty, emotion and sympathy. This commitment therefore fulfills a childhood dream for us, in addition to the added business value,” says Managing Director Ilya Garev.
DRAPALIN would like to use the partnership with TSV 1860 Munich, the interface of sports and health, for joint prevention and educational work and design various projects in the field of health promotion. “Our goal is to work with the Lions to educate soccer fans on health issues,” adds Ilya Garev, for whom sport is an essential prerequisite for a healthy and balanced life.
For Löwen Managing Director Marc-Nicolai Pfeifer, it is always a special sign of trust and at the same time a great team success when entrepreneurs get involved with their favorite club. “The Garev brothers fully identify with TSV 1860 Munich. With its medicinal cannabis products, DRAPALIN makes an important contribution to maintaining and promoting health. We are very much looking forward to the journey together and to supporting them in their responsible work.”
DRAPALIN PHARMACEUTICALS GMBH
When the “Cannabis als Medizin” law came into force on March 10, 2017, the possibilities for prescribing cannabis medicines were expanded. In December of the same year, DRAPALIN Pharmaceuticals GmbH was founded in Munich. Since then, the company has ensured a safe and seamless supply of cannabis products to pharmacies and was the first company to bring medical cannabis from Africa (Lesotho) to German pharmacies. Furthermore, in addition to high-quality products, DRAPALIN focuses on simple ordering processes, a reliable logistics network and comprehensive information for professionals. This also includes transparent and open communication with regard to manufacturers, places of origin and production processes. This ensures that all aspects that have an influence on the quality of such a special plant-based medicinal product are disclosed to the medical community.
More info at: www.drapalin.de
